VELSIPITY is a drug that reduces the number of lymphocytes (a type of white blood cell) in the blood by binding to human sphingosine 1-phosphate receptors that is used to treat adults with moderately to severely active ulcerative colitis (UC).
https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-velsipity
No hay comentarios:
Publicar un comentario